ArticleBreast cancer research and treatment2022

Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years.

Lisi M Dredze et al.PubMed ↗Publisher ↗

No numbers read from the abstract.